Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBTB: Hyoscine Butylbromide and Lidocaine for Pain in HSG
NCT02710305Phase 2Completed
- Sponsor
- Assiut University
- Start
- Apr 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyoscine butylbromide, lidocaine 10% oropharyngeal spray in procedural pain, sponsored by Assiut University. Started Apr 2016; status: completed.
02
Drugs
hyoscine butylbromidelidocaine 10% oropharyngeal spray
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT02710305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02710305.